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Dear Prof Nielsen 
 
We would like you to consider our paper entitled “The Saccharomyces cerevisiae quinone oxidoreductase 
Lot6p:  inhibition, stability and cooperativity” for publication in FEMS Yeast Research. 
 
We believe that this paper is suitable for publication because: 
1. It documents the steady state enzyme kinetics of Lot6p with NADH as well as with NADPH (which 
has been the focus of previous studies). 
2. It establishes assays to measure the thermal stability of Lot6p and shows that several compounds 
can stabilize Lot6p in a concentration dependent manner. 
3. It shows that the same group of compounds act as inhibitors of Lot6p – and that some of these 
compounds act with negative cooperativity, inferring information transmission is possible between 
the active sites.  To our knowledge, this is the first report of negative cooperativity in Lot6p (or 
the functionally related “nitroreductase” enzymes in bacteria). 
4. It presents molecular models which suggest a plausible molecular mechanism for this information 
transmission. 
5. It presents an experimental test of this mechanism by altering a key residue in the proposed 
communication pathway which reduces the degree of cooperativity observed. 
 
We hope that you will agree that this paper is suitable for publication and look forward to hearing from you 
in the near future. 
 
Yours sincerely 
 
David J Timson 
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Abstract 
Lot6p (EC 1.5.1.39; Ylr011wp) is the sole quinone oxidoreductase in the budding 
yeast, Saccharomyces cerevisiae.  Using hexahistdine tagged recombinant Lot6p, we 
demonstrated that the enzyme can function with either NADH or NADPH as an 
electron donor; no cooperativity was observed with these substrates.  The NQO1 
inhibitor curcumin, the NQO2 inhibitor resveratrol, the bacterial nitroreductase 
inhibitor nicotinamide and the phosphate mimic vanadate all stabilise the enzyme as 
judged by thermal scanning fluorimetry.  All except vanadate have no observable 
effect on the chemical crosslinking of the two subunits of the Lot6p dimer.  These 
compounds all inhibit Lot6p’s oxidoreductase activity and all except nicotinamide 
exhibit negative cooperativity.  Molecular modelling suggests that curcumin, 
resveratrol and nicotinamide all bind over the isoalloxazine ring of the FMN cofactor 
in Lot6p.  However, resveratrol and curcumin stretch further from the cofactor and 
contact an α-helix that links the two active sites.  Mutation of Gly-142, which forms 
part of this helix, to serine does not greatly affect the kinetics or stability of the 
enzyme.  However, this variant shows less cooperativity towards resveratrol and 
vanadate.  This suggests a plausible hypothesis for the transmission of information 
between the subunits and, thus, the molecular mechanism of negative cooperativity in 
Lot6p. 
 
Keywords:  Quinone oxidoreductase; resveratrol; negative cooperativity; 
nitroreductase; FMN-containing enzyme 
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Introduction 
Many species contain relatively non-specific quinone oxidoreductases.  The best 
characterised of these is the human NAD(P)H quinone oxidoreductase 1 (NQO1, DT-
diaphorase, EC 1.6.5.2).  This enzyme has attracted considerable interest because of 
its role in vitamin K metabolism, its potential as an anti-cancer drug target and its 
ability to stabilise the tumour suppressor protein p53 (Anwar et al., 2003; Gong et al., 
2007; Nolan et al., 2007; Gong et al., 2008; Dinkova-Kostova & Talalay, 2010; Tie et 
al., 2011).  NQO1 is a dimeric enzyme with an FAD cofactor tightly bound to both 
subunits (Li et al., 1995).  This enzyme is a target for the anticoagulant drug 
dicoumarol (Hosoda et al., 1974; Rase et al., 1976).  In humans, there is a second, 
structurally similar enzyme, NQO2 (EC 1.10.99.2) (Long & Jaiswal, 2000; Vella et 
al., 2005).  The functions and substrates of NQO2 are currently less clear, although it 
is known that this enzyme is inhibited by resveratrol (Buryanovskyy et al., 2004).  
Bacteria have a range of quinone oxidoreductases including the NQO1-like MdaB, the 
tetrameric oxidoreductase WrbA, the azoreductase AzoR and the so-called 
nitroreductases (e.g. NemA, NfsA, NfsB, YdjA) (Zenno et al., 1996a; Zenno et al., 
1996b; Kobori et al., 2001; Lovering et al., 2001; Adams & Jia, 2006; Ito et al., 2006; 
Patridge & Ferry, 2006; Andrade et al., 2007; Carey et al., 2007; Choi et al., 2008; 
Hong et al., 2008; Prosser et al., 2010; Mercier et al., 2013).  The name of the last 
group arises due to their ability to catalyse the reduction of a range of nitrogenous 
compounds, for example nitrobenzene, trinitrotoluene, chloramphenicol, and the pro-
drug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) (Anlezark et al., 1992; 
Caballero et al., 2005; Smith et al., 2007; Yanto et al., 2010).  In the budding yeast, 
Saccharomyces cerevisiae, there is one such enzyme, Lot6p (EC 1.5.1.39; Ylr011wp) 
(Zhang et al., 2001).  This enzyme resembles the bacterial azo- and nitroreductases in 
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that it is dimeric and uses FMN, not FAD, as its tightly bound cofactor (Liger et al., 
2004).  Despite this difference it still catalyses similar reactions to NQO1 and MdaB 
(Liger et al., 2004; Sollner et al., 2007). 
 
All quinone oxidoreductases characterised to date have a substituted enzyme (“ping-
pong”) mechanism in which a reducing agent (usually NADH or NADPH), transfers a 
hydride to the FAD or FMN cofactor.  The oxidised NAD(P)
+
 then leaves the active 
site, enabling the second substrate to enter and be reduced by the cofactor (Hosoda et 
al., 1974; Sollner et al., 2007; Sollner et al., 2009b).  The range of possible substrates 
is broad.  In addition to a wide range of quinones and quinone derivatives, human 
NQO1 has been shown in vitro to catalyse the reduction of aromatic nitrogen 
compounds and iron(III) ions (Sarlauskas et al., 1997; Anusevicius et al., 2002; 
Miseviciene et al., 2006; Newsome et al., 2007; Onyenwoke & Wiegel, 2007). 
 
Lot6p was first identified as the protein encoded by one of a diverse group of low 
temperature (LOT) sensitive genes.  This group also included fructose 1,6-
bisphosphate aldolase (FBA1 or LOT1), a ribosomal subunit (RPL2B or LOT2), a 
nucleolar RNA processing enzyme (NOP1 or LOT3), a gene of unknown function 
(LOT5) (Zhang et al., 2001).  The structure of Lot6p has been solved and revealed a 
typical flavodoxin fold (Liger et al., 2004).  The enzyme has been shown to catalyse 
the NADPH-dependent reduction of a range of biologically relevant quinones 
including 1,4-benzoquinone, 1,4-naphthoquinone and duroquinone (Sollner et al., 
2007) in addition to ferricyanide, azo dyes and nitrocompounds (Liger et al., 2004).  
The activity with quinones is important in minimising toxicity by these compounds:  a 
strain deleted for LOT6 is less viable than the wild-type in the presence of micromolar 
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concentrations of 1,4-benzoquinone, whereas one which overexpressed the protein 
was more viable (Sollner et al., 2007).  Like NQO1, Lot6p has roles beyond its 
enzymatic activity.  It interacts directly with the 20S proteasome.  Reduction of the 
FMN in 20S-associated Lot6p results in the recruitment of the transcription factor 
Yap4p and protects Yap4p from proteosomal degradation (Sollner et al., 2009c).  
Lot6p also induces apoptosis:  strains deleted for LOT6 are less likely to undergo 
apoptosis when challenged with hydrogen peroxide (Sollner et al., 2009a). 
 
In contrast to mammalian NQO1 and NQO2, relatively little data has been collected 
on the biochemical properties of Lot6p.  Here we extend previous enzymological and 
biochemical work by describing Lot6p’s kinetics, inhibition and stability to thermal 
denaturation.  We describe, for the first time in detail, the enzyme’s kinetics with 
NADH as a reducing agent and quantify its inhibition by the organic compounds 
curcumin, resveratrol and nicotinamide.  These compounds were selected for their 
ability to bind to the active sites of NQO1, NQO2 and bacterial nitroreductases 
respectively (Buryanovskyy et al., 2004; Tsvetkov et al., 2005; LinWu et al., 2012).  
Vanadate ions were also studied as a phosphate analogue.  In some cases, but not all, 
these compounds acted with negative cooperativity.  Models of Lot6p in complex 
with these compounds were built in order to help explain their different behaviour.  
These models informed site-directed mutagenesis studies which further illuminated 
cooperativity in Lot6p. 
 
Materials and Methods 
Expression and purification of wild type and mutant Lot6p 
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The coding sequence for LOT6 was amplified by PCR using a single colony from 
Saccharomyces cerevisiae strain BY4741 (MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
EUROSCARF Consortium, Germany) as a template. The product was inserted into 
pET-46 Ek/LIC (Merck, Nottingham, UK) and competent E. coli cells (NovaBlue 
GigaSingles, Merck) were transformed with the annealed Ek/LIC vector and insert. 
Colonies resulting from this transformation were picked and grown shaking at 37 °C 
overnight in 5 ml of Luria-Burtani (LB) broth supplemented with ampicillin (100 µg 
ml
-1
), plasmid DNA was isolated using a miniprep kit (Yorkshire Biosciences, York, 
UK) and the presence of inserts verified by restriction digestion and PCR. Competent 
E. coli HMS174(DE3) were transformed with the plasmid DNA and a single colony 
picked and grown shaking overnight at 37 °C  in 100 ml of LB supplemented with 
ampicillin (100 µg ml
-1
); DNA was isolated using a midiprep kit (Sigma, Poole, UK) 
and sequenced by GATC Biotech, (Konstanz, Germany). 
 
Another colony was picked and grown overnight shaking at 37 °C in 5 ml of LB broth 
supplemented with 100 µgml
-1
 ampicillin. The culture was diluted into 1 l of the same 
medium  and grown at 37 °C for 4 h until mid-log phase was reached (A600~0.6). The 
culture was induced by the addition of IPTG to a final concentration of 1.7 mM, and 
grown for a further 4 h at 37 °C. The cells were then collected by centrifugation at 
4200 g for 15 min and the pellets resuspended in buffer R (50mM HEPES-OH pH 
7.4; 150mM NaCl; 10% v/v glycerol). Sonication on ice (30 s pulses at 100 W with 
30 s breaks for cooling) broke the cells and insoluble material was removed by 
centrifugation (24,000 g for 15 min). The supernatant was poured into a column 
containing 1 ml cold nickel agarose resin (His-select, Sigma, Poole, UK) which had 
been pre-equilibrated with 25 ml of buffer A (50 mM HEPES-OH pH 7.4; 500 mM 
Page 8 of 45
ScholarOne Support 1-434/964-4100
FEMS Yeast Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
7 
 
NaCl; 10% v/v glycerol), and allowed to pass through under gravity. The column was 
then washed with 50 ml of buffer A. Lot6p was eluted by application of two 2 ml 
volumes of buffer A supplemented with imidazole (250 mM). The fraction(s) 
containing Lot6p was identified by 10% SDS-PAGE and were dialysed overnight at 4 
°C against 1 l of buffer R supplemented with 2 mM dithiothreitol (DTT).  
 
Site-directed mutagenesis was carried out by the QuikChange method (Wang & 
Malcolm, 1999) and the mutation verified by DNA sequencing of the complete LOT6 
coding sequence (GATC Biotech).  The mutant enzyme was expressed and purified 
using the same procedures as for the wild type. 
 
Protein concentrations were determined using the method of Bradford (Bradford, 
1976) using BSA as a standard and the purified Lot6p stored in 20 µl and 50 µl 
aliquots frozen at -80 °C. 
 
Enzyme kinetic analysis of Lot6p 
Lot6p activity was measured at 30 ºC in 50 mM HEPES, pH 7.3 using either NADH 
or NADPH as the electron donor and DCPIP as the electron acceptor. Reaction rates 
were determined by measuring the rate of decrease in absorbance at 600 nm resulting 
from the reduction of DCPIP (70 µM). The enzyme concentration ranged from 1.25 
nM to 10 nM.  Absorbance readings were taken every 5 s and all reactions were 
carried out in triplicate in 96-well plates. A calibration curve of A600 against [DCPIP] 
was constructed in triplicate in a 96-well plate to determine a value for εL in the Beer 
Lambert Law, A=εLc were A is absorbance, c is concentration, ε is the molar 
extinction coefficient of DCPIP and L is the pathlength. The resulting equation of the 
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line was used to convert all rates in terms of change in absorbance at 600 nm, to rates 
in terms of change in concentration of DCPIP. 
 
To ensure initial, enzyme-catalyzed rates were obtained, rates for the non-enzymatic, 
direct reduction of DCPIP by both NADH and NADPH were determined at each 
concentration of electron donor with 70 µM DCPIP. These background rates were 
then subtracted from the rates obtained from the linear section at the beginning of 
each progress curve with enzyme included. 
 
Km,app and Vmax,app values for each electron donor were determined, at a constant 
DCPIP (70 µM) by plotting enzyme-catalyzed rate (v) divided by the enzyme 
concentration ([E]) against the corresponding NADH or NADPH concentration.  The 
data were fitted to a modified form of the Michaelis-Menten equation (1) using non-
linear curve fitting (Marquardt, 1963) as implemented in Graphpad Prism 5.0 
(GraphPad Software Inc, CA, USA.).  All points were weighted equally. 
v/[E]=kcat,app[S]/Km,app+[S] (1) 
where kcat,app is the apparent turnover number (equal to the apparent maximal rate, 
Vmax,app, divided by the enzyme concentration), Km,app is the apparent Michaelis-
Menten constant, [E] is the concentration of Lot6p dimer and [S] is the concentration 
of either NADH or NADPH. 
 
Inhibition kinetics 
The effect of potential inhibitors (resveratrol, nicotinamide, curcumin and vanadate 
ions) on the enzyme-catalyzed rate measured at three concentrations of NADH and 
three concentrations of NADPH with a constant DCPIP concentration (70 µM). 
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Dilution series of resveratrol and curcumin were prepared such that the final volume 
of DMSO in each reaction mixture was 0.5% (v/v). Nicotinamide and sodium 
metavanadate were dissolved in 50 mM HEPES pH 7.3.  Dixon plots (Dixon, 1953) 
for each concentration of electron donor were constructed and the apparent inhibition 
constant, Ki,app was obtained by determining the inhibitor concentration at which the 
lines corresponding to each NAD(P)H concentration intercepted. 
 
A concentration range for each inhibitor was chosen based on these Ki,app values and 
an inhibitor titration was carried out using a concentration approximately equal to 
Km,app for NADH (250 µM) or NADPH (100 µM) and DCPIP (70 µM).  Linearized 
Hill plots(-log10(v/(v0-v)) against -log10[inhibitor], where v is the rate of the inhibited 
reaction and v0 is the rate in the absence of inhibitor) were constructed for each 
inhibitor; the gradient of these is the Hill coefficient, h (Hill, 1910). 
 
Crosslinking and limited proteolysis 
Increasing concentrations of the chemical cross-linkers bissulfosuccinimidylsuberate 
(BS
3
) and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
were added to a constant concentration of Lot6p (35 µM dimer) which had been 
preincubated at 30 °C for 5 min.  The reaction was allowed to proceed for 30 min 
after which time it was stopped by the addition of an equal volume of SDS loading 
buffer (120 mM TrisHCl pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 5% (w/v) 
bromophenol blue, 1% (w/v) DTT).  Samples were denatured by heating at 95 °C for 
5 min and analysed by 10% SDS PAGE. An optimum concentration of each 
crosslinker was chosen and the reaction repeated in the presence of each inhibitor. 
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Differential scanning fluorimetry 
Lot6p was diluted in 50 mM HEPES, pH 7.3 to final concentration of 0.25 µM dimer 
in a final volume of 20 µl. The samples were loaded, in triplicate, into a Rotor-Gene 
Q cycler (Qiagen) and the high resolution melt protocol was used. Lot6p was 
subjected to an increase in temperature from 25 °C to 95 °C in steps of 1 K (no gain 
optimisation) with excitation at 460 nm and emission measured at 510 nm throughout, 
thereby exploiting the fluorescence of its cofactor, FMN (Forneris et al., 2009). The 
melting temperature (Tm) of the enzyme was determined from the first derivative of 
the melting curve, using the inbuilt analysis software. A dilution series of each ligand 
(except curcumin which fluoresces in the same region as FMN (Chignell et al., 1994)) 
was prepared such that the final volume of DMSO in the reaction mixture was 0.5% 
v/v. Reactions were prepared in triplicate and kept on ice until loading into the 
instrument. The melting temperature for each concentration of ligand was plotted 
against the corresponding concentration of ligand and the data were fitted to equation 
(2) using non-linear curve fitting in GraphPad Prism. 
∆Tm= ∆Tm,max[ligand]/(KD,app+[ligand]) (2) 
where ∆Tm max is the maximum, limiting change in melting temperature (Tm), and 
KD,app is the apparent dissociation constant for ligand and Lot6p.  
 
Molecular modelling 
Models of Lot6p with ligands bound were based on the experimentally determined x-
ray crystal structure (PDB:  1T0I) (Liger et al., 2004).  This structure was aligned 
with that of NQO2 with resveratrol bound (PDB: 1SG0 (Buryanovskyy et al., 2004)) 
using PyMol (http://www.pymol.org).  Lot6p and the resveratrol molecules were 
saved into a single .pdb file which was then energy minimised and computationally 
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solvated using YASARA (Krieger et al., 2009) to generate the final model.  
Nicotinamide was modelled using the structure of NQO1 bound to NADP
+
 (Li et al., 
1995).  In this case, the structural alignment between the proteins was poor and so the 
structures were aligned using three atoms (C8, N3 and N10) in the isoalloxazine ring 
of the FAD or FMN cofactor.  NADP
+
 was then inserted into the Lot6p structure and 
this was used as a template to insert a nicotimamide molecule (from the RCSB PDB 
Ligand Expo; http://ligand-expo.rcsb.org/) which overlapped the nicotinamide moiety 
of NADP
+
.  The resulting structure was then energy minimised in YASARA to create 
the final model.  Since there are no currently available structures of curcumin bound 
to a quinone oxidoreductase, this molecule was fitted into the active site by aligning 
the O1, C9 and C14 atoms of resveratrol with equivalent atoms in one ring of 
curcumin (from Ligand Expo) and assuming that the molecule adopts a similar 
orientation in Lot6p’s active site.  This initial model was then energy minimised in 
YASARA to generate the final model.  The three final models are available as 
supplementary data to this paper. 
 
Results 
Recombinant expression and dimerisation of Lot6p 
Lot6p can be expressed in, and purified from, E. coli with a typical yield of 
approximately 12 mg purified protein per litre of initial culture (Fig 1a). Crosslinking 
with both EDC and BS
3
 showed that Lot6p is a dimer (Fig. 1b) and the amount of 
crosslinking observed was unchanged in the presence of resveratrol, nicotinamide and 
curcumin; however, vanadate ions reduced the amount of crosslinked product 
observed (Fig. 1c). 
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Steady state enzyme kinetics: no cooperativity with either NADH or NADPH 
Lot6p can use both NADH and NADPH as electron donors; the Km,app for NADH was 
273±35 µM and for NAD(P)H it was 131±22 µM. The kcat,app values for NADH and 
NADPH were 297±11 s
-1
 and 449±29 s
-1
 respectively (Fig. 2). Lot6p exhibits 
Michaelis-Menten kinetics (i.e. no detectable cooperativity) towards both electron 
donors with a Hill coefficient of 1.05±0.08 and 0.99±0.07 for NADH and NADPH 
respectively (Fig. 2). 
 
Quinone oxidoreductase inhibitors stabilise Lot6p  
The melting temperature of Lot6p, as judged by TSF, was 56.9±0.4 °C in HEPES 
buffer. Lot6p is slightly stabilised by phosphate ions; the Tm increased to 58.9±0.4 °C 
in 50 mM phosphate buffer (Supplementary Fig. S1). Resveratrol and nicotinamide 
stabilised Lot6p in a saturatable, concentration-dependent manner. The apparent 
dissociation constants with resveratrol and nicotinamide were 0.091±0.026 mM and 
24.5±3.4 mM respectively (Fig. 3). 
 
Inhibition of Lot6p is negatively cooperative with some compounds 
The oxidoreductase activity of Lot6p was inhibited by curcumin, resveratrol, 
nicotinamide and vanadate.  Dixon plots for all four compounds with NADH and 
NADPH as the reducing agent intersected as expected for competitive inhibition 
(Dixon, 1953).  For each inhibitor except vanadate, the Ki,app values obtained with 
NADH and NADPH were similar (Fig. 4; Table 1). Of the organic compounds, 
nicotinamide has the highest Ki,app followed by curcumin and resveratrol which was 
the most effective inhibitor tested (Fig. 4; Table 1). Lot6p exhibits negative 
cooperativity with the inhibitors resveratrol, curcumin, and vanadate when inhibiting 
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with respect to both NADH and NADPH; in contrast, nicotinamide does not induce 
negative cooperativity in Lot6p with either electron donor (Fig. 5; Table 2). 
 
Molecular modelling of Lot6p and inhibitors 
Nicotinamide, resveratrol and curcumin were all predicted to bind in the enzyme’s 
active site, lying across the partly exposed surface of the isoalloxazine ring of the 
FMN cofactor, consistent with their role as competitive inhibitors (Fig. 6, left 
column).  The two larger molecules, resveratrol and curcumin, extend beyond the 
active site into a cleft between the two polypeptide chains of the Lot6p dimer.  
Interestingly, resveratrol is predicted to make contact with an α-helix (residues Ser-
130 to Leu-143) which links the two active sites of the dimeric enzyme (Fig. 6, right 
column).  Curcumin contacts the equivalent α-helix in the other subunit.  The smaller 
molecule, nicotinamide, does not contact this helix.  Vanadate could, potentially, bind 
at a variety of sites including those for the three phosphate groups in NADPH.  In the 
absence of any structures of quinone oxidoreductases bound to vanadate, no 
modelling was attempted with this inhibitor. 
 
Mutation of a key residue reduces the degree of negative cooperativity 
From the molecular models, we noticed that resveratrol contacts the α-helix which 
links the two active sites close to a glycine residue (Gly-142).  Given the role of 
glycine in protein flexibility and the importance of such mobility in phenomena such 
as cooperativity (Goodey & Benkovic, 2008), we reasoned that altering this residue 
might affect cooperativity towards the inhibitors.  Alteration of Gly-142 to serine 
results in an active enzyme, which is dimeric, has Michaelis-Menten kinetics with 
NADH and is inhibited by resveratrol and vanadate (Supplementary Fig S2, S3, S4; 
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Table 3).  The apparent inhibition constants for these compounds with respect to 
NADH were increased approximately two-fold (Table 3).  The enzyme is slightly 
more stable towards thermal denaturation than the wild type (Tm values of 60.9±0.2 
ºC and 61.5±0.6 ºC in phosphate and hepes buffer respectively; Supplementary Fig. 
S5).  This is consistent with a less flexible overall structure.  Resveratrol and 
nicotinamide both stabilise the G142S variant protein, with apparent dissociation 
constants similar to those of the wild-type (Table 3, Supplementary Fig. S6).  
However, the degree of negative cooperativity towards resveratrol and vanadate was 
less than that seen with the wild type; for both compounds, the Hill coefficient rose 
towards one (Table 3, Fig. 7). 
 
Discussion 
Previous studies of Lot6p have concentrated on its activity with NADPH as an 
electron donor (Sollner et al., 2007).  Here, it is demonstrated that NADH functions as 
an electron donor, albeit with a higher apparent Michaelis constant and lower turnover 
number.  Lot6p’s location in the cytoplasm (Sollner et al., 2007) means that it is more 
likely to encounter NADPH since the NADPH:NADH concentration ratio in the 
cytoplasm is generally greater than one (Jacbonson & Kaplan, 1957).  However, it has 
been demonstrated that, in S. cerevisiae, environmental changes (e.g. altered nutrient 
sources) can alter this ratio (Satrustegui et al., 1983; Nissen et al., 2001; Celton et al., 
2012; Ask et al., 2013).  Therefore, both reducing agents are likely to be important in 
vivo.  Despite the dimeric nature of the enzyme, and the involvement of residues from 
both polypeptides in the two active sites, no cooperativity with respect to NADH or 
NADPH was detected in our experiments. 
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Through thermal scanning fluorimetry experiments, we established that resveratrol, 
nicotinamide and vanadate ions all bind to, and stablise, Lot6p.  Furthermore, these 
molecules (and curcumin) competitively inhibit the enzyme with respect to NAD(P)H 
– all except nicotinamide with negative cooperativity.  Negative cooperativity towards 
inhibitors has previously been observed with mammalian NQO1 when inhibited with 
dicoumarol – although the molecular mechanism and physiological significance 
remains obscure (Rase et al., 1976).  The molecular models (Fig. 6) suggest a 
potential mechanism for inter-active site communication and also why nicotinamide is 
unable to initiate this.  Both resveratrol and curcumin are predicted to contact an 
extended α-helix at the interface between the two polypeptides of the dimer.  This 
helix links the two active sites and so it is plausible that alterations to its conformation 
induced by an inhibitor binding at one active site may affect the conformation of the 
second active site.  Nicotinamide is predicted to bind parallel to the FMN cofactor and 
does not make contact with this helix; therefore it would be unable to initiate 
information transmission between the active sites.  Given that, like all models, these 
should be treated with some caution, we tested the hypothesis by mutating a glycine 
residue in this helix.  The resulting protein had similar kinetic properties and stability 
to the wild type protein, but showed less negative cooperativity (i.e. higher value of h) 
towards resveratrol and vanadate.  This result supports the hypothesis that this helix 
plays a key role in transmitting information between the active sites in Lot6p.  It also 
confirms that the non-Michaelian kinetics observed with inhibitors arises from 
genuine inter-active site cooperativity and not from intra-molecular aggregation or 
some other artefact. 
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The physiological importance of the negative cooperativity observed in Lot6p is not 
yet clear.  In many signalling systems, negative cooperativity functions to extend the 
concentration range over which the system is sensitive to concentration changes 
(Ferrell, 2009).  Therefore it is possible that some, as yet unidentified, naturally 
occurring molecule in the yeast cytoplasm regulates Lot6p’s activity and perhaps also 
its role in apoptosis or in the proteasome. 
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Figure legends 
Figure 1:  Expression and dimerization of recombinant Lot6p.  (A) SDS-PAGE 
(10%) showing the progress of a typical expression and purification of Lot6p.  (B) 
Crosslinking of recombinant Lot6p with EDC (0, 4, 8, 16, 32, 64 mM) and BS
3
 (0, 50, 
100, 200, 400, 800 µM).  The effects of solvent (DMSO 1 %(v/v)) and ligands 
(resveratrol 0.7 mM, curcumin 40 µM, nicotinamide 160 mM, vanadate 18 mM) on 
crosslinking by EDC (32 mM) and BS
3
 (800 µM).  In (A), (B) and (C) lane M 
represents the molecular mass markers (with masses shown to the left of the gel in 
kDa). 
 
Figure 2:  Lot6p kinetics with electron donors.  Initial rates of DCPIP (70 µM) 
reduction were measured and plotted as a function of either NADH or NADPH 
concentration (top graphs).  These data were replotted as linear Hill plots (bottom 
graphs).  Each point represents the mean of three independent determinations and the 
error bars the standard error of these means. 
 
Figure 3:  Ligands stabilise Lot6p against thermal denaturation.  Increasing 
concentrations of resveratrol and nicotinamide were mixed with Lot6p (0.25 µM) in 
Hepes-OH buffer (pH 7.3) and the melting temperature determined by TSF.  The first 
derivative curves of the fluorescence against temperature (top) were used to determine 
Tm values, which were plotted against ligand concentration (bottom).  Each point 
represents the mean of three values and error bars the standard errors of these means. 
 
Figure 4:  Ligands inhibit the oxidoreductase activity of Lot6p.  Initial rates of 
DCPIP reduction were measured at different NADH (left column) and NADPH (right) 
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concentrations in the presence of increasing concentrations of ligand.  See Materials 
and Methods for the conditions of these experiments.  Dixon plots (1/v against 
[Inhibitor]) were constructed and the Ki,app estimated for each inhibitor.  Each point 
represents the mean of three separate determinations and the error bars the standard 
errors of these means. 
 
Figure 5:  Some inhibitors exhibit negative cooperativity.  Linear Hill plots with 
(A) NADH and (B) NADPH as the reducing agent were constructed in order to 
determine the Hill coefficient, h.  See Materials and Methods for the conditions of 
these experiments.  Each point represents the mean of three separate determinations 
and the error bars the standard errors of these means. 
 
Figure 6:  Molecular modelling predicts how the inhibitors bind to Lot6p.  In the 
left hand column a close up of the active site with inhibitor bound is shown.  In the 
right hand column the inhibitor is shown bound to one active site and, in the case of 
curcumin and resveratrol, contacting an α-helix (orange) which connects the two 
active sites of the enzyme.  (Note that curcumin and resveratrol contact the equivalent 
helix in different subunits.)  FMN is shown in yellow. 
 
Figure 7:  The G142S variant of Lot6p has reduced negative cooperativity 
towards some inhibitors.  Linear Hill plots showing the effect of resveratrol and 
vanadate on the NADH mediated reduction of DCPIP.  See Materials and Methods for 
the conditions of these experiments.  Each point represents the mean of three separate 
determinations and the error bars the standard errors of these means. 
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Tables 
Table 1: 
Inhibition of Lot6p. 
 
Inhibitor 
Ki,app/mM 
with NADH with NADPH 
Resveratrol 0.067±0.003 0.063±0.033 
Curcumin 5.8±1.0 5.0±2.5  
Nicotinamide 20.0±4.8 11.9±4.5 
Vanadate 21.1±4.3 3.4±0.2 
 
Values are the mean of the intersection points in the Dixon plot and the errors are the 
standard deviation of these means. 
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Table 2: 
Hill coefficients (h) for the inhibition of Lot6p. 
 
Inhibitor 
Hill coefficient (h) 
with NADH with NADPH 
Resveratrol 0.75±0.11 0.83 ±0.05 
Curcumin 0.60±0.09 0.61 ±0.10 
Nicotinamide 1.02±0.07 1.03 ±0.05 
Vanadate 0.44±0.05 0.71 ±0.01 
 
Values were determined by constructing three separate linearised Hill plots, each 
based on triplicate data.  The values quoted are the means of the three estimates of h 
and the errors the standard deviations of these means. 
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Table 3 
Properties of the G142S variant of Lot6p 
Property Value 
Km,app (NADH) 1200±110 µM 
kcat,,app (NADH) 160+5 s
-1 
 
h (NADH) 1.08±0.03  
Ki,app (Resveratrol) 0.059±0.030 mM 
Ki,app (Vanadate) 46±16 mM 
KD,app (Resveratrol) 0.22±0.07 mM 
KD,app (Nicotinamide) 20.8±2.3 mM 
h (Resveratrol) 0.94±0.04 
h (Vanadate) 0.82±0.08 
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Supplementary Figure S1:  Phosphate ions slightly stabilise Lot6p.  Melting point 
determination of Lot6p (0.25 µM) by TSF in Hepes-OH (pH 7.3) and phosphate buffer (pH 
7.4). 
 
Supplementary Figure S2:  The G142S variant of Lot6p forms dimers.  Upper panels:  
Crosslinking of the G142S variant with EDC (0, 4, 8, 16, 32, 64 mM) and BS
3
 (0, 50, 100, 
200, 400, 800 µM).  Lower panels:  The effects of solvent (DMSO 1 %(v/v)) and ligands 
(resveratrol 0.7 mM, curcumin 40 µM, nicotinamide 160 mM, vanadate 18 mM) on 
crosslinking by EDC (32 mM) and BS
3
 (800 µM).  In all gels, lane M represents the 
molecular mass markers (with masses shown to the left of the gel in kDa).  
 
Supplementary Figure S3:  The G142S variant of Lot6p has Michaelis-Menten kinetics.  
Initial rates of DCPIP (70 µM) reduction were measured and plotted as a function of NADH 
(upper panels).  The data were replotted as a linear Hill plot (lower panels).  Each point 
represents the mean of three independent determinations and the error bars the standard error 
of these means. 
 
Supplementary Figure S4:  The G142S variant of Lot6p is inhibited by resveratrol and 
vanadate.  Initial rates of DCPIP reduction were measured at different NADH concentrations 
in the presence of increasing concentrations of inhibitor.  See Materials and Methods for the 
conditions of these experiments.  Dixon plots (1/v against [Inhibitor]) were constructed and 
the Ki,app estimated for each inhibitor.  Each point represents the mean of three separate 
determinations and the error bars the standard errors of these means. 
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Supplementary Figure S5:  The G142S variant of Lot6p has similar thermal stability to 
the wild type. Melting point determination of G142S (0.25 µM) by TSF in Hepes-OH (pH 
7.3) and phosphate buffer (pH 7.4). 
 
Supplementary Figure S6:  The G142S variant of Lot6p is stabilised by resveratrol and 
nicotinamide.  Increasing concentrations of resveratrol and nicotinamide were mixed with 
G142S (0.25 µM) in Hepes-OH buffer (pH 7.3) and the melting temperature determined by 
TSF.  The first derivative curves of the fluorescence against temperature were used to 
determine Tm values, which were plotted against ligand concentration.  Each point represents 
the mean of three values and error bars the standard errors of these means. 
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